Holt, MI - Orchid Orthopedic Solutions (Orchid), a global leader in the design and manufacture of orthopedic implants, announced that Josh Pang joined the company as Chief Commercial Officer (CCO) on February 1, 2021.
Josh comes to Orchid from Conmed, where he held roles of increasing responsibility and influence. He most recently held the role of Vice President of Orthopedic Sales, where he was responsible for managing the United States sales force for the Orthopedic business. He has a reputation for growing market share through relationship building and concentrated execution. Previous to Conmed, Josh held various roles at Smith and Nephew, Pfizer and J&J.
“One of the key enablers of Orchid’s business strategy is a focus on our customers. We know that having a strong relationship with our customers helps drive growth. To continue building on our foundation of customer relationships, I am pleased to announce the addition of Josh Pang to the Orchid Leadership Team,” said Nate Folkert, Orchid’s Chief Executive officer.
About Orchid Orthopedic Solutions
Orchid is a world leader in orthopedic medical device solutions, providing design and manufacturing services globally. As a strategic partner, Orchid has the capability of providing entire implant procedure and product design services, as well as, complete single source manufacturing. Orchid has the broadest portfolio in the industry, ranging from design and development through finished goods manufacturing and packaging, improving customers’ supply chains and adhering to the highest quality standards in the industry. Orchid specializes in implants, single use instruments and innovative technologies within joint reconstruction, hips, knees, spine, trauma, extremities and dental. For further information, please see www.orchid-ortho.com.